Tradestie Institutional Equity Comparison Engine

SION vs EVMN โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

EVMN Overall Edge

EVMN Captures Institutional Edge (2โ€“1 Pillars ยท 2โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Evommune, Inc. (EVMN) driven by superior Momentum & Technical, Options & Structure while SION counters with relative strength in Growth & Margin. Fundamentally, SION trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus EVMN at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, SION sits in BREAKDOWN (10th %ile IV; Dealer Gamma Walls on Pro) against EVMN sits in SURGE (53rd %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
SION N/M vs EVMN N/M Fwd P/E
Growth & Margin Winner SION
Op Margin 0.0% vs 0.0% ยท YoY +0.0% vs +0.0%
Momentum & Technical Winner EVMN
1Y -91.3% vs -61.0% ยท 52W Pos 0% vs 8%
Options & Structure Winner EVMN
BREAKDOWN (10th %ile IV) vs SURGE (53rd %ile IV)
SION NASDAQ
Sionna Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$3.12
-6.31% 1D
Market Cap $150.6M
1M Return -19.79%
1Y Return -91.3%
Forward P/E N/M
Unified AI Score
45.6 / 100 HOLD
Tech 34.0 Fund 50.0 Flow 67.0 Mom 59.0
EVMN US Equity
Evommune, Inc.
Pharmaceutical Preparations
$7.10
-6.95% 1D
Market Cap $315.5M
1M Return +37.33%
1Y Return -61.03%
Forward P/E N/M
Unified AI Score
30.0 / 100 SELL
Tech 50.0 Fund 35.0 Flow 69.0 Mom 44.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: SION -91.3% EVMN -61.03% Spread: +30.27 pp (EVMN Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
SION TTM Op. Margin: 0.0% EVMN TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on SION vs EVMN. Trailing 12-month operating profitability (SION 0.0% vs EVMN 0.0%) and valuation multiples (SION N/M vs EVMN N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: SION (3) vs EVMN (2)
Institutional Metric SION EVMN Criterion Row Winner
Market Capitalization Scale $150.6M $315.5M Larger Scale EVMN
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% +0.0% Higher Growth Tie
Operating Margin (TTM) Profitability 0.0% 0.0% Higher Margin Tie
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -39.0% -69.5% Higher ROE SION
52-Week Range Position Momentum 0% ($3โ€“$55) 8% ($5โ€“$33) Stronger Trend EVMN
Beta / 30D Volatility Risk Regime 1.97ฮฒ ยท 78% Vol 1.05ฮฒ ยท 118% Vol Lower Realized Risk SION
Unified Institutional Score Composite Signal 45.6 / 100 (HOLD) 30.0 / 100 (SELL) Higher Composite SION

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full SION vs EVMN Buy Guide
SION BREAKDOWN
45d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 10th %ile
IV Regime Compressed (<25th %ile)
Live SION Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
EVMN SURGE
5d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 53rd %ile
IV Regime Balanced (25thโ€“60th %ile)
Live EVMN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither SION nor EVMN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.